Prognostic value of histological type in @entity43 : a retrospective analysis of 223 XXXX .

@entity1 @entity43 @entity41 @entity5 @entity3
BACKGROUND: @entity1 with FIGO stage @entity43 have a poor but non-uniform prognosis. This study aimed to compare the survival of @entity1 with @entity5 ( @entity5 ) and clear cell or mucinous @entity5 (non- @entity5 ). METHODS: Data for 223 @entity1 who underwent surgery between 1987 and 2010 and were diagnosed by centralized pathology review and were retrospectively analysed. The @entity1 included 169 with @entity5 @entity5 and 54 with non- @entity5 @entity5 . RESULTS: The median overall survivals (OSs) of the @entity5 and non- @entity5 groups were 3.1 and 0.9 years, respectively (P<0.001). Six @entity1 (2.7%), all with non- @entity5 @entity5 , died within 6 weeks after the initial surgery. Multivariate OS analysis revealed that performance status, @entity41 , metastatic sites, no debulking surgery, and non- @entity5 @entity5 were independent poor prognostic factors. For @entity1 with non- @entity5 @entity5 , prognosis was more favourable for single-organ @entity3 , except for liver or distant lymph nodes, no @entity41 , and resection of @entity3 (median OS: 4.1, 4.6, and 2.6 years, respectively). CONCLUSIONS: In @entity43 , non- @entity5 @entity5 are associated with a significantly poorer prognosis and higher rates of early mortality compared to @entity5 @entity5 . Therefore, careful management and development of new strategies are required.
